a message from the membership committee chairman

Notes of the American Society for Clinical Pharmacology and Therapeutics A MESSAGE FROM THE MEMBERSHIP COMMITTEE CHAIRMAN It is my pleasure to present the new members of our Society; they number 77. There were 74 members dropped from our rolls producing a net gain of 3 members for a total membership of 2,149. Admittedly, this represents little growth from the 1,985 members of 1990; steady new membership is being offset by the attrition of those we dropped or who resigned and the inevitable deaths. While this latter trend will likely continue, our challenge is to increase recruitment efforts. The Society continues its healthy mix with 21% women, which is similar to the past four years. Non-physician new members was 47% and similar to previous years. Over the past 2 years your Membership Committee and the Board of Directors introduced a methodology for nominating new members. Some of you have responded and I’m sure others will in the future as we try to streamline these efforts. Forty percent of the new members were nominated. I am impressed at the quality of our new members, many of which have already demonstrated consider- able productivity in our discipline and will no doubt help create and establish our future. Besides the quality, we continue as a balanced Society represent- ing our many faces. It has been a pleasure to serve as your membership chairman which is completed this year. Dr. Judith Jones will be the new chairperson and I’m certain she will do an excellent job. Thomas L. Whitsett, MD Chairman, Membership Committee NEW.MEMBERS of the SOCIETY Welcome to the following individuals elected to membership in the American Society for Clinical Pharmacology and Therapeutics during the period March, 1996 to March, 1997. NEW FULL MEMBERS Joseph W. Aquilina, MD Mayo Clinic Edward Dennis Bashaw, PharmD Food and Drug Administration Gary J. Bennett, PhD Allegheny University of the Health Sciences Douglas L. Blowey, MD The Children’s Mercy Hospital Samuel W. Boellner, MD Clinical Investigation Specialists Bruno X. Boutouyrie, MD Rhone-Poulenc Rorer Rene Bruno, PhD Rhone-Poulenc Rorer Giles V. Campion, MD, PhD SmithKline Beecham Pharmaceuticals Robert L. Capizzi, MD Jefferson Medical College Jose Caro, MD Lilly Research Laboratories Allen E. Cato, III, PhD Abbott Laboratories Michael L. Christensen, PharmD University of Tennessee, Memphis 608 MAY 1997 CLINICAL PHARMA COLOGY & THERAPEUTICS

Upload: thomas-l

Post on 02-Jul-2016

213 views

Category:

Documents

1 download

Report

Download

Embed Size (px):

TRANSCRIPT

Page 1: A MESSAGE FROM THE MEMBERSHIP COMMITTEE CHAIRMAN

Notes of the American Society for Clinical Pharmacology and Therapeutics A MESSAGE FROM THE MEMBERSHIP COMMITTEE CHAIRMAN

It is my pleasure to present the new members of our Society; they number 77. There were 74 members dropped from our rolls producing a net gain of 3 members for a total membership of 2,149. Admittedly, this represents little growth from the 1,985 members of 1990; steady new membership is being offset by the attrition of those we dropped or who resigned and the inevitable deaths. While this latter trend will likely continue, our challenge is to increase recruitment efforts. The Society continues its healthy mix with 21% women, which is similar to the past four years. Non-physician new members was 47% and similar to previous years.

Over the past 2 years your Membership Committee and the Board of Directors introduced a methodology for nominating new members. Some of you have

responded and I’m sure others will in the future as we try to streamline these efforts. Forty percent of the new members were nominated.

I am impressed at the quality of our new members, many of which have already demonstrated consider- able productivity in our discipline and will no doubt help create and establish our future. Besides the quality, we continue as a balanced Society represent- ing our many faces.

It has been a pleasure to serve as your membership chairman which is completed this year. Dr. Judith Jones will be the new chairperson and I’m certain she will do an excellent job.

Thomas L. Whitsett, MD Chairman, Membership Committee

NEW.MEMBERS of the SOCIETY Welcome to the following individuals elected to membership in the American Society for Clinical

Pharmacology and Therapeutics during the period March, 1996 to March, 1997.

NEW FULL MEMBERS

Joseph W. Aquilina, MD Mayo Clinic

Edward Dennis Bashaw, PharmD Food and Drug Administration

Gary J. Bennett, PhD Allegheny University of the Health Sciences

Douglas L. Blowey, MD The Children’s Mercy Hospital

Samuel W. Boellner, MD Clinical Investigation Specialists

Bruno X. Boutouyrie, MD Rhone-Poulenc Rorer

Rene Bruno, PhD Rhone-Poulenc Rorer

Giles V. Campion, MD, PhD SmithKline Beecham Pharmaceuticals